← Back to Search
Toxicity Evaluation Of Engineered Nanoparticles For Medical Applications Using Pulmonary Epithelial Cells
R. Guadagnini, K. Moreau, Salik Hussain, F. Marano, S. Boland
Published 2015 · Materials Science, Medicine
Download PDFAnalyze on Scholarcy
Abstract There are a multitude of nanoparticles (NPs) which have shown great potentials for medical applications. A few of them are already used for lung therapeutic and diagnostic purposes. However, there are few toxicological studies which determine possible adverse pulmonary responses. It is thus important to propose in vitro screening strategies to evaluate the pulmonary toxicity of NPs used in nanomedicine. Our goal was to determine the cellular effects of several biomedical NPs with different physico-chemical characteristics (chemical nature, size and coating) to establish suitable tests and useful benchmark NPs. The effects of poly(lactic-co-glycolic acid) (PLGA), silica, iron oxide and titanium dioxide NPs were studied using human bronchial (16HBE) and alveolar epithelial cells (A549). We evaluated cytotoxicity, reactive oxygen species (ROS) production and pro-inflammatory response in both cell lines. We demonstrated that PLGA NPs are good candidates for negative control NPs and SiO2 NPs were revealed to be the best benchmark NPs. Coating of Fe3O4 with sodium oleate, a known biocompatible compound, led to an unexpected increase in cytotoxicity. Moreover, 16HBE cells are more sensitive than A549 cells and propidium iodide uptake is a more sensitive cytotoxicity test than WST-1. The measurement of oxidative stress does not systematically allow us to predict cellular responses and different other cellular endpoints should also be addressed. We conclude that a battery of assays and cell lines are necessary to accurately evaluate the pulmonary effects of NPs and that PLGA and SiO2 NPs are suitable candidates respectively for negative and positive controls.
This paper references
Superparamagnetic iron oxide nanoparticles (SPIONs): development, surface modification and applications in chemotherapy.
M. Mahmoudi (2011)
Nanotoxicology: An Emerging Discipline Evolving from Studies of Ultrafine Particles
G. Oberdörster (2005)
The toxicity, transport and uptake of nanoparticles in the in vitro BeWo b30 placental cell barrier model used within NanoTEST
S. Correia Carreira (2015)
Development of functionalized superparamagnetic iron oxide nanoparticles for interaction with human cancer cells.
A. Petri-Fink (2005)
Biodegradable nanoparticles meet the bronchial airway barrier: how surface properties affect their interaction with mucus and epithelial cells.
S. Mura (2011)
Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers.
I. Slowing (2008)
Toxicity screenings of nanomaterials: challenges due to interference with assay processes and components of classic in vitro tests
R. Guadagnini (2015)
Carbon black and titanium dioxide nanoparticles induce pro-inflammatory responses in bronchial epithelial cells: Need for multiparametric evaluation due to adsorption artifacts
S. Val (2009)
Health Effects of Nanoparticles
C. Ostiguy (2006)
Nanomedicine for respiratory diseases.
H. Swai (2009)
Understanding the nanoparticle–protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles
T. Cedervall (2007)
Nanomaterial health effects
MC Powell (2006)
Carbon black and titanium dioxide nanoparticles elicit distinct apoptotic pathways in bronchial epithelial cells
Salik Hussain (2010)
Stress reaction of kidney epithelial cells to inorganic solid-core nanoparticles
B. Halamoda Kenzaoui (2012)
Lung exposure to nanoparticles modulates an asthmatic response in a mouse model
S. Hussain (2010)
The Coming Era of Nanomedicine
Fritz Allhoff (2009)
Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology
G. Oberdörster (2010)
Understanding biophysicochemical interactions at the nano-bio interface.
A. Nel (2009)
Surface chemistry influences cancer killing effect of TiO2 nanoparticles.
Paul Thevenot (2008)
Oxidative stress and proinflammatory effects of carbon black and titanium dioxide nanoparticles: role of particle surface area and internalized amount.
Salik Hussain (2009)
Similar cellular effects induced by diesel exhaust particles from a representative diesel vehicle recovered from filters and Standard Reference Material 1650.
S. Boland (2001)
Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging.
S. Parveen (2012)
PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect.
Sarbari Acharya (2011)
Deciphering the mechanisms of cellular uptake of engineered nanoparticles by accurate evaluation of internalization using imaging flow cytometry
S. Vranic (2012)
Translocation of SiO2-NPs across in vitro human bronchial epithelial monolayer
I. George (2013)
Nanoparticles used in medical applications for the lung: hopes for nanomedicine and fears for nanotoxicity
S. Boland (2011)
Toxicity evaluations of superparamagnetic iron oxide nanoparticles: cell "vision" versus physicochemical properties of nanoparticles.
M. Mahmoudi (2011)
Nanomaterial health effects--Part 2: Uncertainties and recommendations for the future.
Maria C Powell (2006)
This paper is referenced by
Cytotoxicity and oxidative stress responses of silica-coated iron oxide nanoparticles in CHSE-214 cells
K. Srikanth (2016)
Interactions of oxidized multiwalled carbon nanotube with cadmium on zebrafish cell line: The influence of two co-exposure protocols on in vitro toxicity tests.
M. Morozesk (2018)
Personalized medicine in hematology — A landmark from bench to bed
G. Badalian-Very (2014)
Copper doping enhanced the oxidative stress–mediated cytotoxicity of TiO2 nanoparticles in A549 cells
J. Ahmad (2018)
Comparative study of cyto‐ and genotoxic potential with mechanistic insights of tungsten oxide nano‐ and microparticles in lung carcinoma cells
Srinivas Chinde (2018)
Synthesis, characterization and toxicological evaluation of iron oxide nanoparticles in human lung alveolar epithelial cells.
S. Dwivedi (2014)
Towards an alternative testing strategy for nanomaterials used in nanomedicine: Lessons from NanoTEST
M. Dušinská (2015)
Risk Assessment and Risk Minimization in Nanomedicine: A Need for Predictive, Alternative, and 3Rs Strategies
L. Accomasso (2018)
The Toxicity Phenomenon and the Related Occurrence in Metal and Metal Oxide Nanoparticles: A Brief Review From the Biomedical Perspective
Shokouh Attarilar (2020)
Nano titanium exposure induces dose- and size-dependent cytotoxicity on human epithelial lung and colon cells
Durgaiah Gandamalla (2019)
The bovine serum albumin protein corona on nanoparticles: investigating the effects of changing pH, substrates, and ions
Brittany E. Givens (2017)
In vitro toxicity screening of magnetite nanoparticles by applying mesenchymal stem cells derived from human umbilical cord lining
T. Coccini (2019)
The role of reactive oxygen species in the genotoxicity of surface-modified magnetite nanoparticles.
M. Mesárošová (2014)
Hazard Assessment of Polymeric Nanobiomaterials for Drug Delivery: What Can We Learn From Literature So Far
Sandra Jesus (2019)
Risikobewertung von Nanopartikeln in Konsumgütern
Stephan Hackenberg (2014)
Pulmonary toxicity of nanomaterials: a critical comparison of published in vitro assays and in vivo inhalation or instillation studies.
R. Landsiedel (2014)
NanoTEST in a Nutshell
M. Dušinská (2015)
Modeling better in vitro models for the prediction of nanoparticle toxicity: a review.
Y. Cao (2020)
Potential Hazards of Nanoparticles
Hoda Jafarizadeh-Malmiri (2019)
Suitability of human and mammalian cells of different origin for the assessment of genotoxicity of metal and polymeric engineered nanoparticles
H. Cowie (2015)
Dependence of Nanoparticle Toxicity on Their Physical and Chemical Properties
A. Sukhanova (2018)
Titanium dioxide nanoparticles induce size-dependent cytotoxicity and genomic DNA hypomethylation in human respiratory cells
Y. Ma (2017)
Macrophages participate in local and systemic inflammation induced by amorphous silica nanoparticles through intratracheal instillation
Man Yang (2016)
Physicochemical characterization of oily particles emitted from different machining processes
J. Zhang (2016)
Genotoxicity of amorphous silica nanoparticles: Status and prospects.
Mostafa Yazdimamaghani (2019)
Resveratrol prevents nanoparticles-induced inflammation and oxidative stress via downregulation of PKC-α and NADPH oxidase in lung epithelial A549 cells
Hung-Te Hsu (2018)
Overview on biological implications of metal oxide nanoparticle exposure to human alveolar A549 cell line
Ansie Martin (2017)
Acute exposure to silica nanoparticles enhances mortality and increases lung permeability in a mouse model of Pseudomonas aeruginosa pneumonia
Mathilde Delaval (2014)
Novel methodology for labelling mesoporous silica nanoparticles using the 18F isotope and their in vivo biodistribution by positron emission tomography
Santiago Rojas (2015)
Altered Gene Transcription in Human Cells Treated with Ludox® Silica Nanoparticles
C. Fede (2014)
Nano-titanium dioxide bioreactivity with human alveolar type-I-like epithelial cells: Investigating crystalline phase as a critical determinant
S. Sweeney (2015)
High throughput toxicity screening and intracellular detection of nanomaterials
A. Collins (2017)See more